Shannon James Samuel
CIK 0001485417
Director
Filings
15
Latest May 22, 2026
Issuers covered
3
Showing
15 of 15
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +3.2% | +6.4% | +9.0% | -5.8% |
| 90 days | 2 | 100% | +11.4% | +11.4% | +13.1% | +9.6% |
| 180 days | 2 | 0% | -3.8% | -3.8% | -2.3% | -5.2% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Shannon James Samuel has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| MNKD | Mannkind Corp | 6 | May 22, 2026 |
| HZNP | Horizon Therapeutics Public Ltd Co | 5 | Oct 6, 2023 |
| XLO | Xilio Therapeutics, Inc. | 4 | Mar 30, 2026 |
All filings
15 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|